MassMutual snags majority stake in clean energy finance firm

MassMutual snags majority stake in clean energy finance firm | Insurance Business America

Life & Health

MassMutual snags majority stake in clean energy finance firm

Firm “one of the premier leaders in the sustainable financing space”

Life & Health

By
Ryan Smith

Massachusetts Mutual Life Insurance Company has announced that it has purchased a majority interest in Counterpointe Sustainable Advisors (along with its subsidiaries, collectively “Counterpointe”), a provider of commercial property assessed clean energy (C-PACE), sustainable real estate, and creative energy solutions financing.

“We believe Counterpointe’s extensive experience, track record, and established platform make it one of the premier leaders in the sustainable financing space for US commercial real estate,” said Eric Partlan, chief investment officer at MassMutual.

“This transaction provides MassMutual with the opportunity to create an innovative investment platform to manage sustainable investment assets and provide solutions-based financing for clean energy projects, ultimately helping to reduce the carbon footprint of commercial real estate and energy infrastructure across the country.”

“The investment from MassMutual will allow Counterpointe to expand its market-leading origination platform and establish an active impact investment management firm for debt assets including green mortgages, sustainable private debt, C-PACE and green energy finance,” said Eric J. Alini, CEO and CIO of Counterpointe. “We couldn’t be more excited about our relationship with MassMutual, who is a forward-thinking institutional investor.”

As part of the transaction, Counterpointe has announced that Christopher Hoeffel will be joining the company as president and chief operating officer. Most recently, Hoeffel was co-founder and president of CoreVest. Prior to that, he served as global co-head of commercial mortgages at Bear Stearns.

Have something to say about this story? Let us know in the comments below.